- Promote commercialization of unique technology from Japan and expansion of overseas business by combining Konica Minolta’s protein-sensitive quantitative detection technology with Ambry’s genetic diagnostic technology
- Establish genetic testing business to contribute to the promotion of precision medicine in Japan
Our Portfolio
Ambry Genetics Corporation
Outline | Genetic testing services for breast cancer, colon cancer, and other diseases |
---|---|
Website | |
Industry | Health/medicine |
Commercialization stage | Utilization of overseas management resources |
Provided Support
Authorized Investment | USD 400M (maximum) |
---|---|
Announcement Date | Jul 06, 2017 |
Investment Structure |